Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's LG Electronics Teams Up With International Vaccine Institute To Inoculate Kids In Kenya, Ethiopia

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korean giant LG Electronics and the Seoul-based International Vaccine Institute have tightened cooperation in the area of vaccines aimed at Africa by signing a memorandum of understanding

You may also be interested in...



LG Life Sciences-Green Cross Tie-up Might Not Trigger Matching Alliances By Other Korean Drug Makers

SEOUL - A recent deal covering cooperation in domestic and global sales between South Korea's second largest pharmaceutical company, Green Cross, and 10-ranked LG Life Sciences has not yet triggered any similar tie-ups by other major drug players

LG Life Sciences-Green Cross Tie-up Might Not Trigger Matching Alliances By Other Korean Drug Makers

SEOUL - A recent deal covering cooperation in domestic and global sales between South Korea's second largest pharmaceutical company, Green Cross, and 10-ranked LG Life Sciences has not yet triggered any similar tie-ups by other major drug players

LG Life Science Tops R&D Investment List of Korea-Listed Pharmas

SEOUL - Of the 37 local Korean pharmas listed on Korea's main KOSPI stock market, LG Life Science topped local pharmas in R&D investment last year in both scale and in proportion to its sales, according to a report released by a lawmaker in an Oct. 6 National Assembly session

UsernamePublicRestriction

Register

OM011382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel